radiolabeled VEGF (Sibtech/Stanford)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameradiolabeled VEGF (Sibtech/Stanford)
Drug Alias NameLu-177-DOTA-PEG-scVEGFLu-scVEGF99mTc-singlechain-VEGF99mTc-HYNIC-VEGFtechnetium-99m-single chain-VEGF +[6] 
ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentBiologics > Protein drugs > Recombinant protein > Fusion protein +[4] 
Mechanisms of ActionVascular endothelial growth factor receptor stimulants
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsAtherosclerosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSibTech IncStanford University
Active IndicationsN/A
Inactive IndicationsAtherosclerosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A